SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is heavily trending after a disappointing forward outlook sparked a fierce debate among investors, with many anticipating further declines due to weak guidance. However, a significant portion of the community views the sharp pullback as an overreaction and a strategic buying opportunity, citing strong underlying demand and long-term potential in its foundry initiatives.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending strongly as geopolitical and economic uncertainties drive a significant flight to safety into precious metals, with many in the community anticipating further record highs as fiat currency trust erodes. However, a vocal segment views the rapid ascent as an unsustainable "mania" and "bubble," expecting a sharp correction, especially with recent de-escalation reports fueling debate over gold's true underlying drivers.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is seeing increased attention following the FDA's Breakthrough Therapy Designation for its lead asset, pemvidutide, for metabolic dysfunction-associated steatohepatitis. The community is buzzing with optimism about pemvidutide's best-in-class profile and eagerly awaiting potential strategic partnerships or an acquisition, which many believe the new CEO is poised to execute. This sentiment is amplified by notable price appreciation and trading volume, suggesting a market rerating in the active GLP-1 and MASH sector.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics (SNSE) is trending due to intense community speculation around a potential short squeeze, fueled by its extremely low float and historical volatility. While many bulls anticipate a significant breakout, a strong contingent of skeptics warns of a pump-and-dump, citing the company's ongoing strategic review for maximizing shareholder value, which includes exploring asset sales, mergers, or an orderly wind-down of operations.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp. is trending following its Memorandum of Understanding with the Government of Gujarat and Kaynes SemiCon to establish India's first Post-Quantum Cryptography semiconductor center, underscoring its crucial role in the evolving quantum security landscape. Community discussions are highly bullish, fueled by CEO Carlos Moreira's presentations at Davos emphasizing the immediate need for quantum-safe chips to protect against advanced threats posed by AI and quantum computing. This has generated significant anticipation for the company's growth and a potential short squeeze.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies (ASTI) is experiencing a surge of attention, primarily driven by Elon Musk's comments on the critical role of lightweight, flexible solar technology for future space-based AI data centers, a niche where ASTI holds existing expertise and strategic partnerships. The community is buzzing with speculation about a potential short squeeze and a multi-day rally, fueled by the stock's low float and high short interest, though some caution remains regarding its historical volatility and potential for dilution.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano Inc. is experiencing intense trading activity as its merger partner, Corvex, announced a long-term NVIDIA H200 GPU deployment, driving significant speculative interest. Traders are sharply divided between those bullish on the low float and AI narrative, and those concerned about prior dilution history and the fundamental value of simply utilizing NVIDIA's hardware.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is currently trending amid extreme natural gas market volatility driven by widespread U.S. winter weather, which has dramatically increased heating demand. The community is sharply divided, with many seeing KOLD as a 'buy the dip' opportunity after its recent declines, while others warn of the 'widow maker' volatility as natural gas prices respond to cold fronts and potential supply impacts. Discussions center on whether the natural gas surge is sustainable or if a mean reversion for KOLD is imminent, making it a highly active, high-risk trade.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is trending after announcing significant financial backing from the French government for a new rare earth metal and alloy production facility, aimed at bolstering integrated supply chains. This strategic development, coupled with partnerships advancing its US-based projects and the launch of a new leveraged ETF, is igniting community discussion about its potential for substantial growth amidst the intensifying global race for critical minerals.

HeyElsa is an AI-powered on-chain execution platform designed to simplify how users and applications interact with crypto and decentralized finance. The platform converts user intent, expressed through natural language or structured inputs, into deterministic on-chain actions such as swaps, bridging, staking, yield optimization, and automated portfolio execution across multiple blockchain networks and protocols.  HeyElsa operates through both a consumer-facing AI Copilot and a business-to-business infrastructure offering, including widgets, SDKs, and agent execution APIs that can be embedded into wallets and applications. The core purpose of the project is to abstract fragmented DeFi interfaces and execution complexity, while maintaining transparency, security, and user control. HeyElsa focuses on real usage, automation, and reliable execution rather than speculative features, aiming to make crypto transactions seamless and operationally efficient.

Elsa

ELSA Crypto is trending due to its recent listing on Coinbase within the Solana ecosystem, attracting significant attention for its alignment with popular sectors like AI Utility and Zero Knowledge Proof technology. The community is actively discussing potential buying opportunities during price pullbacks, while also monitoring initial staker unlocks for market impact. Despite some profit-taking, many observers note increasing volume and strong support, positioning ELSA as a key asset among new crypto listings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $467.35, signifying a +1.35% move from its prior day's close.

Biotech Stocks To Keep An Eye On - January 22nd

Moderna, Brainstorm Cell Therapeutics, ImmunityBio, Danaher, Vertex Pharmaceuticals, argenex, and Recursion Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's...

Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded to Outperform at Royal Bank Of Canada

Royal Bank Of Canada upgraded shares of Vertex Pharmaceuticals from a "sector perform" rating to an "outperform" rating and set a $546.00 price target on the stock in a research report on Thursday...

Boston Common Asset Management LLC Sells 5,164 Shares of Vertex Pharmaceuticals Incorporated $VRTX

Boston Common Asset Management LLC trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 11.2% in the 3rd quarter, according to its most recent filing with the...

Why Is Vertex Pharmaceuticals (VRTX) Stock Trending Overnight?

Vertex Pharmaceuticals shares dipped slightly in after-hours trading following Wednesday's session.read more...

Promising Biotech Stocks To Consider - January 21st

Moderna, ImmunityBio, Danaher, Vertex Pharmaceuticals, argenex, BioNTech, and Legend Biotech are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks...

Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 11.1% in the third quarter, according to the company in its most...

Rakuten Investment Management Inc. Makes New $94.96 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX

Rakuten Investment Management Inc. bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the third quarter, according to the company in its most recent...

Vertex Pharmaceuticals Incorporated $VRTX Stake Boosted by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1.8% during the third quarter, according to its most...

Migdal Insurance & Financial Holdings Ltd. Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX

Migdal Insurance & Financial Holdings Ltd. acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 3rd quarter, according to the company in its...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Policy uncertainty from Trump

Earnings & guidance

Options / dealer positioning

Liquidity & algos

Markets are reacting to a mix of policy headlines, earnings, and positioning. We want to hear what you think is driving volatility the most right now.

What&#39;s the biggest driver of market volatility right now?

Stocktwits

What's the biggest driver of market volatility right now?

Current Price	$467.35
Prev Close	$461.14
Open	$463.74
Dividend Yield	0.00%
50-Day Moving Average	$447.01
Beta	0.54
Avg. Volume	1.31M
PE Ratio	32.94

52-Week High	$519.68
52-Week Low	$362.50
Market Capitalization	$112.16B
EPS (Annual)	-$2.08
Price to Book	6.85
Revenue Per Employee	$1.8M
Enterprise Value/EBITDA	N/A

VRTX
Vertex Pharmaceuticals, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VRTX News

VRTXVertex Pharmaceuticals, Inc.